Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Qui Tam Challenge At 11th Circuit: 4 Takeaways No Photo Available

Dan McKay

An appellate panel weighed the constitutionality of the False Claim Act's whistleblower mechanism. Law360 Healthcare Authority has wha... (more story)

The Most Important Healthcare And Life Science Deals Of 2025 No Photo Available

Yeji Jesse Lee

Attorneys taking stock of 2025 spoke to Law360 about the most important deals of the year, including Pfizer’s high-profile acquisition... (more story)

Bazelon Center Dir. On Disabilities And Medicaid 'Barriers' No Photo Available

Hannah Albarazi

Law360 Healthcare Authority talks to Jennifer Mathis of the Bazelon Center for Mental Health Law about Medicaid, disability law and wh... (more story)